RPL17 and colorectal carcinoma: Based on this pilot study, we registered a phase II clinical trial that is currently recruiting participants to further investigate the effect of this neoadjuvant PD‐1 combination regimen on the treatment of locally advanced (cT4NxM0) pMMR/MSS CRC (ClinicalTrials.gov, NCT04895137).